SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 43 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $20,000 | +53.8% | 24,590 | +68.2% | 0.00% | – |
Q4 2018 | $13,000 | -53.6% | 14,618 | 0.0% | 0.00% | – |
Q3 2018 | $28,000 | +16.7% | 14,618 | -0.0% | 0.00% | – |
Q2 2018 | $24,000 | -17.2% | 14,619 | -3.6% | 0.00% | – |
Q1 2018 | $29,000 | +3.6% | 15,171 | +3.8% | 0.00% | – |
Q4 2017 | $28,000 | +27.3% | 14,619 | -16.9% | 0.00% | – |
Q3 2017 | $22,000 | -31.2% | 17,585 | -30.8% | 0.00% | – |
Q2 2017 | $32,000 | -37.3% | 25,428 | -39.8% | 0.00% | – |
Q1 2017 | $51,000 | -34.6% | 42,247 | +6.5% | 0.00% | – |
Q4 2016 | $78,000 | -56.4% | 39,670 | -21.7% | 0.00% | – |
Q3 2016 | $179,000 | -22.8% | 50,670 | -21.9% | 0.00% | – |
Q2 2016 | $232,000 | -35.2% | 64,873 | -12.3% | 0.00% | – |
Q1 2016 | $358,000 | +3.2% | 73,991 | +25.7% | 0.00% | – |
Q4 2015 | $347,000 | +50.9% | 58,864 | +51.7% | 0.00% | – |
Q3 2015 | $230,000 | -47.8% | 38,798 | +19.7% | 0.00% | – |
Q2 2015 | $441,000 | +137.1% | 32,411 | +123.0% | 0.00% | – |
Q1 2015 | $186,000 | – | 14,532 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 4,492,975 | $5,616,219,000 | 4.42% |
CARL DOMINO INC | 112,719 | $142,000 | 0.16% |
VAN DEN BERG MANAGEMENT I, INC | 243,679 | $307,000 | 0.04% |
ELEMENT CAPITAL MANAGEMENT LLC | 112,735 | $142,000 | 0.03% |
Psagot Value Holdings Ltd. | 195,999 | $247,000 | 0.01% |
ORACLE INVESTMENT MANAGEMENT INC | 50,804 | $64,000 | 0.01% |
B. Riley Wealth Advisors, Inc. | 28,927 | $37,000 | 0.01% |
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 18,894 | $24,000 | 0.01% |
WEALTHSOURCE PARTNERS, LLC | 10,000 | $13,000 | 0.00% |
LMR Partners LLP | 50,168 | $63,000 | 0.00% |